▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Dan Carroll

TMFCane

Dan began writing for the Motley Fool in 2012. He is a health care specialist who also follows the defense industry along with tracking the broader U.S. and international markets.

Recent Articles by Dan Carroll

Feb 28, 2013 by Dan Carroll

Today's 3 Worst Stocks

J.C. Penny's bear of a day tops the market's leading laggards

Feb 28, 2013 by Dan Carroll

The Dow Closes In on Record Highs Despite Sequestration

Stocks surge across the board as Washington scrambles to avoid budget cuts.

Feb 27, 2013 by Dan Carroll

Endo Health Solutions Names New CEO

Former Valeant Pharmaaceuticals President Rajiv De Silva takes the reins.

Feb 27, 2013 by Dan Carroll

Why the Dow's Defying Sequestration Fears

Investors ignore Washington as the markets surge.

Feb 27, 2013 by Dan Carroll

The Diagnostic Edge at Abbott Labs

Don't overlook this growing segment that's bursting with potential

Feb 27, 2013 by Dan Carroll

Medtronic Wins FDA Approval for Longer Stents

Longer lengths of company's Resolute Integrity stent useful for diabetes patients.

Feb 27, 2013 by Dan Carroll

Orbital Sciences Successfully Test Fires Antares Space Launch Vehicle

Successful "hot fire" of Antares rocket completes final ground testing.

Feb 26, 2013 by Dan Carroll

Why Housing Is Sending the Dow to Triple-Digit Gains

Positive data has the markets soaring.

Feb 25, 2013 by Dan Carroll

Quest Diagnostics Selling HemoCue Business for $300 Million

Company using the $300 million sale to help finance stock buyback program

Feb 25, 2013 by Dan Carroll

Alcatel-Lucent, China Mobile Introduce New lightRadio Innovation

lightRadio Metro Radio is designed to meet data needs in fast-growing Chinese cities.

Feb 25, 2013 by Dan Carroll

How Italy's Jitters Are Taking Down the Dow

Markets are concerned that a return by Silvio Berlusconi could unravel the country's recovery.

Feb 25, 2013 by Dan Carroll

Warner Brothers' "Argo" Wins Best Picture

Film pulled in more than $200 million at the box office

Feb 25, 2013 by Dan Carroll

"Identity Thief" Beats Out "Snitch" to Top Weekend Box Office

Universal's film holds off Lionsgate's by $1 million for the weekend's top spot

Feb 25, 2013 by Dan Carroll

It's Time for This Big Pharma to Save Its Future

AstraZeneca is in a world of hurt, and only acquisitions can save its waning future

Feb 22, 2013 by Dan Carroll

Boston Scientific to Launch Neuromodulation Products in Japan

Company inks agreement with Japanese firm Fukuda Denshi for sales and distribution.

Feb 22, 2013 by Dan Carroll

Pfizer's Lyrica Hits Primary Endpoints in Epilepsy Trial

Study meets success for treating patients with partial onset seizures.

Feb 22, 2013 by Dan Carroll

RIAA Blasts Google's Anti-Copyright Infringement Measures

The industry association unloaded on the tech giant in a report card on Thursday

Feb 22, 2013 by Dan Carroll

Sony Steals the Spotlight as Japan Heats Up Inflation

Prime Minister Abe pressures the BoJ, while questions circle over its next governor.

Feb 22, 2013 by Dan Carroll

HP's Irrational Surge Fuels the Dow

While HP is in the thick of its transition, short-term traders go nuts over earnings.

Feb 22, 2013 by Dan Carroll

4 Orphan Drugs Making Waves in 2013

Orphan drugs can be a lucrative business, but which companies are taking the spotlight this year?

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services